OneSkin Company
OnSkin designs anti-aging molecules that fights with skin aging. Its anti-aging molecules uses animal-free 3D human skin and genomic data to find molecules able to truly reverse skin aging and also combines real 3D human skin models and molecular markers to discover and produce the first generation of molecules for personalised anti-aging skincare products, enabling individuals to recover skin ageing and prevent skin diseases.
Total Funding:
$0
Headquarters:
San Francisco, USA
Funding Status:
Seed
Employee Number:
1-10
Estimated Revenue:
$1-10 Mn
Last Funding Type:
Seed
Technology:
Supplements and ingredients
Investor Type:
For Profit
Last Funding Date:
21.05.2017
Investors Number:
3
Founded Date:
01.01.2016
Industry:
Beauty supplements